Table 1.
Baseline characteristics of the subjects.
| Parameters | Intravenous group (n = 70) | Oral group (n = 70) |
|---|---|---|
| Male | 34 (48.5%) | 43 (61.4%) |
| Age | 72.4 ± 10.7 | 66.5 ± 9.9 |
| Weight (kg) | 63.5 ± 13.0 | 63.5 ± 9.4 |
| Hypertension | 26 (37.1%) | 35 (50.0%) |
| DCM | 3 (4.3%) | 12 (17.1%) |
| HCM | 1 (1.4%) | 3 (4.3%) |
| ICM | 0 (0.0%) | 1 (1.4%) |
| CAD | 4 (5.7%) | 14 (20.0%) |
| AF | 33 (47.1%) | 44 (62.8%) |
| Paroxysmal | 9 (12.8%) | 14 (20.0%) |
| Persistent | 24 (34.3%) | 30 (42.8%) |
| INDICATION OF PACING | ||
| SSS | 14 (20.0%) | 22 (31.4%) |
| AVB | 56 (80.0%) | 48 (68.6%) |
| Intrinsic QRS duration, ms | 100.2 ± 31.8 | 107.8 ± 34.7 |
| HV interval, ms | 50.4 ± 8.2 | 52.8 ± 10.3 |
| ECHOCARDIOGRAM | ||
| LVEF, % | 57.1 ± 15.7 | 52.6 ± 17.5 |
| LVEDd, mm | 54.1 ± 10.3 | 56.9 ± 11.3 |
| LAD, mm | 47.3 ± 7.2 | 49.3± 9.7 |
| MEDICATIONS | ||
| Anticoagulant | 34 (48.5%) | 30 (42.8%) |
| Antiplatelet | 12 (17.1%) | 30 (42.8%) |
| ACEI/ARB | 30 (42.8%) | 53 (75.7%) |
| Diuretic | 21 (30.0%) | 35 (50.0%) |
| Statins | 32 (45.7%) | 39 (55.7%) |
DCM, dilated cardiomyopathy; ICM, ischemic cardiomyopathy; HCM, hypertrophic cardiomyopathy; CAD, coronary artery disease; SSS, sick sinus syndrome; AF, atrial fibrillation; AVB, atrioventricular block; AF, atrial fibrillation; AVB, atrioventricular block.